You just read:

Theravance Biopharma Highlights Positive Headline Results from IMPACT Study of Trelegy Ellipta Announced by GlaxoSmithKline and Innoviva

News provided by

Theravance Biopharma, Inc.

Sep 20, 2017, 16:05 ET